Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.
about
Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy and safety of paritap ...... tients aged 70 years or older.
@en
Efficacy and safety of paritap ...... tients aged 70 years or older.
@nl
type
label
Efficacy and safety of paritap ...... tients aged 70 years or older.
@en
Efficacy and safety of paritap ...... tients aged 70 years or older.
@nl
prefLabel
Efficacy and safety of paritap ...... tients aged 70 years or older.
@en
Efficacy and safety of paritap ...... tients aged 70 years or older.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of paritap ...... tients aged 70 years or older.
@en
P2093
Adrian Goldis
Ana-Maria Singeap
Anca Trifan
Carmen Preda
Carol Stanciu
Catalina Mihai
Ciprian Brisc
Cristina Cijevschi Prelipcean
Egidia Miftode
Florin Alexandru Caruntu
P2860
P356
10.1097/MD.0000000000009271
P407
P577
2017-12-01T00:00:00Z